Search Results - "Rieko IIjima"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Acteoside inhibits type Ι allergy through the down-regulation of Ca/NFAT and JNK MAPK signaling pathways in basophilic cells by Motojima, Hideko, Villareal, Myra O, Iijima, Rieko, Han, Junkyu, Isoda, Hiroko

    Published in Journal of natural medicines (01-10-2013)
    “…We have previously reported that acteoside inhibits the release of β-hexosaminidase from immunoglobulin E (IgE)-sensitized and bovine serum albumin-stimulated…”
    Get full text
    Journal Article
  2. 2

    Involvement of the TGF-β1 Derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and Bone Formation by Ide, Youichi, Yamanaka, Eri, Namiki, Yasuko, Iijima, Rieko, Harada, Katsuhiko, Ishi, Hiromi, Kawahara, Jun-ichi, Doi, Kunio

    Published in Journal of Toxicologic Pathology (2002)
    “…Bone marrow fibrosis and new bone formation were induced by Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) injection in…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice by Nakagawa, R, Nagafune, I, Tazunoki, Y, Ehara, H, Tomura, H, Iijima, R, Motoki, K, Kamishohara, M, Seki, S

    Published in The Journal of immunology (1950) (01-06-2001)
    “…The role of mouse liver NK1.1 Ag(+) T (NKT) cells in the antitumor effect of alpha-galactosylceramide (alpha-GalCer) has been unclear. We now show that,…”
    Get full text
    Journal Article
  5. 5

    Inhibitory effect of acteoside isolated from Cistanche tubulosa on chemical mediator release and inflammatory cytokine production by RBL-2H3 and KU812 cells by Yamada, Parida, Iijima, Rieko, Han, Junkyu, Shigemori, Hideyuki, Yokota, Shinichi, Isoda, Hiroko

    Published in Planta medica (01-10-2010)
    “…The immediate-type allergic reaction is involved in many allergic diseases such as asthma, allergic rhinitis, and sinusitis. In this study, we investigated the…”
    Get more information
    Journal Article
  6. 6

    Treatment of hepatic metastasis of the Colon26 adenocarcinoma with an α-galactosylceramide, KRN7000 by NAKAGAWA, R, MOTOKI, K, UENO, H, IIJIMA, R, NAKAMURA, H, KOBAYASHI, E, SHIMOSAKA, A, KOEZUKA, Y

    Published in Cancer research (Chicago, Ill.) (15-03-1998)
    “…Colorectal liver metastasis is clinically a major problem. We examined the antitumor activity of KRN7000, an alpha-galactosylceramide, on mice with liver…”
    Get full text
    Journal Article
  7. 7

    Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells by Nakagawa, R, Serizawa, I, Motoki, K, Sato, M, Ueno, H, Iijima, R, Nakamura, H, Shimosaka, A, Koezuka, Y

    Published in Oncology research (01-01-2000)
    “…Liver metastasis of primary tumors is clinically a major problem. We examined the antitumor activity of KRN7000, an alpha-galactosylceramide, in mice with…”
    Get more information
    Journal Article
  8. 8

    Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production by Nakagawa, R, Motoki, K, Nakamura, H, Ueno, H, Iijima, R, Yamauchi, A, Tsuyuki, S, Inamoto, T, Koezuka, Y

    Published in Oncology research (1998)
    “…Liver metastasis of primary tumor is a clinically major problem. KRN7000, an alpha-galactosylceramide, significantly augments natural killer (NK) activity of…”
    Get more information
    Journal Article
  9. 9

    Involvement of the TGF- beta 1 Derived from Megakaryocyte in the PEG-rHuMGDF- Induced Myelofibrosis and Bone Formation by Ide, Youichi, Yamanaka, Eri, Namiki, Yasuko, Rieko IIjima, Harada, Katsuhiko, Ishi, Hiromi, Kawahara, Jun-Ichi, Doi, Kunio

    Published in Journal of toxicologic pathology (01-01-2002)
    “…Bone marrow fibrosis and new bone formation were induced by Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) injection in…”
    Get full text
    Journal Article
  10. 10

    Involvement of the TGF-[beta]1 Derived from Megakaryocyte in the PEG-rHuMGDF-Induced Myelofibrosis and Bone Formation by Ide, Youichi, Yamanaka, Eri, Namiki, Yasuko, Iijima, Rieko, Harada, Katsuhiko, Ishi, Hiromi, Kawahara, Jun-ichi, Doi, Kunio

    Published in Journal of toxicologic pathology (01-01-2002)
    “…Bone marrow fibrosis and new bone formation were induced by Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) injection in…”
    Get full text
    Journal Article
  11. 11